| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.8 |